Biotech & Clinical R&D Facilities: Structural biology teams requiring strict batch-to-batch consistency and fully auditable certificates of analysis (COAs) to satisfy internal quality control frameworks
Eli Lilly reiterated to NPR that the drugs have been "available since August." "Our current manufacturing investment of over $20 billion in the past four years is the most significant in our history, and will allow us to continue increasing capacity to safely bring these medicines to people who need them," Eli Lilly spokesperson Courtney Kasinger wrote in an email
Zhou X, Chen Y, Cui L, Shi Y, Guo C
Dietary modifications should be sustainable and culturally appropriate, focusing on long-term behavior change rather than restrictive dieting
Marx N, Husain M, Lehrke M, Verma S, Sattar N